Mumbai, Oct. 19 -- Focus Prism, a Coimbatore-based food services platform that raised Rs.145 crore from OAKS Asset Management last month, has acquired FoodExo Chennai Pvt. Ltd, underscoring the consol... Read More
Mumbai, Oct. 15 -- The government's decision to sell a 60.72% stake in IDBI Bank to Canada's Fairfax Financial Holdings for Rs.52,878 crore sends a strong signal that India is open to foreign investme... Read More
Mumbai, Oct. 7 -- Veeda Lifesciences has relaunched the process of exploring a majority stake sale in a deal that will value the company at $300-400 million and facilitate exits for its existing share... Read More
Mumbai, Oct. 5 -- Neysa, an Indian artificial intelligence (AI) cloud platform, is in the process of raising a $200 million tranche led by Blackstone and other existing investors, as a part of its lar... Read More
Mumbai, Sept. 30 -- A consortium of General Atlantic (GA) and Renova Hospitals has inched closer to acquiring American Oncology Institute (AOI) from Siemens Healthineers in a deal that could potential... Read More
Mumbai, Sept. 29 -- Permira and TPG Capital have acquired stakes in Cloudnine Hospitals from early investors True North and TPG NewQuest in a $450 million secondary transaction at a valuation of about... Read More
Mumbai, Sept. 25 -- True North has picked up a stake in initial public offering (IPO)-bound InMobi in a largely secondary transaction, three people familiar with the matter said. The investment is the... Read More
Mumbai, Sept. 22 -- India's equity capital markets activity may fall below last year's record $60 billion as a subdued start to 2026, uncertainty over crude oil and global interest rates weigh on deal... Read More
New Delhi, Sept. 16 -- Global private-equity firm EQT Group plans to invest about $50 billion in India over the next four years, expanding beyond large buyouts into data centres, infrastructure, mid-m... Read More
Mumbai, Sept. 15 -- Orbicular Pharmaceutical Technologies has attracted early interest from private equity firms including Warburg Pincus and CVC Capital Partners, as the specialty pharmaceutical firm... Read More